The Motley Fool Discussion Boards

Previous Page

Industry Discussions / Biotechnology


Subject:  Re: DYAI Date:  6/18/2019  10:48 AM
Author:  Cosmid Number:  25119 of 25561

Hey 2k10,

The good: current mammalian expression systems are expensive and inefficient.

The ugly:

. The CEO is a journalism major with a checkered past. His pay equal to annual revenues.
. Prior to becoming CEO, he was in the pumice industry inventing better stonewash products.
. Six employees and five of these are executives. In other words, they are a virtual company.
. I would speculate that they “discovered” the C1 system from work an off-shore post-doc did.
. None of the executives appear to be scientists, and the website doesn’t list board composition nor scientific advisory board.
. While they tout all of the current biologics as candidates for the C1 system, nobody is going to switch midstream.
. There are hundreds of mycologists working on mammalian protein expression.

Not for me.

Copyright 1996-2021 trademark and the "Fool" logo is a trademark of The Motley Fool, Inc. Contact Us